Literature DB >> 3354306

Motor neuron disease in Cantabria.

J M López-Vega1, J Calleja, O Combarros, J M Polo, J Berciano.   

Abstract

Sixty-two patients with motor neuron disease (MND), encompassing amyotrophic lateral sclerosis (ALS), progressive bulbar palsy (PBP) and progressive muscular atrophy (PMA), were selected from within a defined area (Cantabria) in northern Spain, from 1974 to 1985. The annual incidence of MND was 1.01 per 100,000 inhabitants and the prevalence rate was 3.52 per 100,000. The male to female ratio was 1.78:1. Age-specific incidence rates increased with advanced age, with a maximum between 60 and 69 years for males and over 70 years for females. The median age at onset was 60.5 years. The average interval between the onset symptoms and diagnosis was 11 months. Fifty-three per cent of the patients had conventional or pseudopolyneuritic ALS, 36% had PBP and 11% had PMA. There were three familial cases. Two PMA patients had had acute poliomyelitis. The mean duration of the disease was 26.6 months and was significantly longer in males aged under 60 years. The survival rates in 50 patients with adequate follow-up were 18% after 5 years from onset and 6% after 10 years.

Entities:  

Mesh:

Year:  1988        PMID: 3354306     DOI: 10.1111/j.1600-0404.1988.tb06965.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  7 in total

1.  Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.

Authors:  A M Chancellor; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

2.  The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-07       Impact factor: 10.154

Review 3.  Retinoids and motor neuron disease: Potential role in amyotrophic lateral sclerosis.

Authors:  Javier Riancho; Maria T Berciano; Maria Ruiz-Soto; Jose Berciano; Gary Landreth; Miguel Lafarga
Journal:  J Neurol Sci       Date:  2015-12-02       Impact factor: 3.181

Review 4.  Prognostic factors in ALS: A critical review.

Authors:  Adriano Chiò; Giancarlo Logroscino; Orla Hardiman; Robert Swingler; Douglas Mitchell; Ettore Beghi; Bryan G Traynor
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

5.  Trends in motor neuron disease: association with latitude and air lead levels in Spain.

Authors:  Ana Santurtún; Alejandro Villar; Manuel Delgado-Alvarado; Javier Riancho
Journal:  Neurol Sci       Date:  2016-04-20       Impact factor: 3.307

6.  Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm.

Authors:  Marwa Elamin; Peter Bede; Anna Montuschi; Niall Pender; Adriano Chio; Orla Hardiman
Journal:  J Neurol       Date:  2015-04-11       Impact factor: 4.849

7.  Timeliness of diagnosis in motor neurone disease: a population-based study.

Authors:  Colette Donaghy; Alison Dick; Orla Hardiman; Victor Patterson
Journal:  Ulster Med J       Date:  2008-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.